C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 4 715 JPY -0.53% Market Closed
Market Cap: 37.9B JPY
Have any thoughts about
Cuorips Inc?
Write Note
Cuorips Inc
/
Balance Sheet
/
PP&E Net

Cuorips Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cuorips Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuorips Inc
TSE:4894
PP&E Net
¥514.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
PP&E Net
¥6.5B
CAGR 3-Years
23%
CAGR 5-Years
21%
CAGR 10-Years
30%
PeptiDream Inc
TSE:4587
PP&E Net
¥17.2B
CAGR 3-Years
39%
CAGR 5-Years
24%
CAGR 10-Years
59%
Takara Bio Inc
TSE:4974
PP&E Net
¥50.6B
CAGR 3-Years
13%
CAGR 5-Years
16%
CAGR 10-Years
10%
Pharma Foods International Co Ltd
TSE:2929
PP&E Net
¥4.6B
CAGR 3-Years
-1%
CAGR 5-Years
26%
CAGR 10-Years
21%
S
StemRIM Inc
TSE:4599
PP&E Net
¥185.8m
CAGR 3-Years
-17%
CAGR 5-Years
80%
CAGR 10-Years
N/A
No Stocks Found

Cuorips Inc
Glance View

Market Cap
37.8B JPY
Industry
Biotechnology

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Intrinsic Value
234.89 JPY
Overvaluation 95%
Intrinsic Value
Price
C
What is Intrinsic Value?

See Also

What is Cuorips Inc's PP&E Net?
PP&E Net
514.1m JPY

Based on the financial report for Mar 31, 2024, Cuorips Inc's PP&E Net amounts to 514.1m JPY.

What is Cuorips Inc's PP&E Net growth rate?
PP&E Net CAGR 1Y
-9%

Over the last year, the PP&E Net growth was -9%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.